- 22025358OWN - NLMSTAT- MEDLINEDA  - 20120116DCOM- 20120529IS  - 1477-111X (Electronic)IS  - 0267-6591 (Linking)VI  - 27IP  - 1DP  - 2012 JanTI  - Long-term use of the CentriMag(R) Ventricular Assist System as a right      ventricular assist device: a case report.PG  - 65-70LID - 10.1177/0267659111424634 [doi]AB  - Right ventricular failure (RVF) following implantation of a left ventricular      assist system (LVAS) is associated with high morbidity and mortality.( 1-4 )      Numerous centers have reported short-term use of the CentriMag ((R)) Ventricular       Assist System (CVAS) (Levitronix LLC, Waltham, MA) for treatment of cardiogenic      shock, decompensated heart failure and right ventricular failure (RVF) following       LVAS implantation.( 5-9 ) The present report reviews the clinical course of a      patient requiring long-term right ventricular support utilizing the CVAS,      following a HeartMate ((R)) II LVAS (Thoratec Corp. Pleasanton, CA) implantation.      Elevated cytotoxic antibody levels complicated the patient's treatment plan by      precluding orthotropic heart transplantation. The CVAS operated for 304 days      without mechanical difficulty until replaced with the HeartWare ((R)) Ventricular      Assist System (HeartWare Inc. Miramar, FL).FAU - Griffith, K EAU  - Griffith KEAD  - Cardiovascular Center Perfusion Services, University of Michigan Hospitals, Ann      Arbor, MI, USA. kegriff@med.umich.eduFAU - Jenkins, EAU  - Jenkins EFAU - Stulak, JAU  - Stulak JFAU - Paugh, TAU  - Paugh TFAU - Pagani, F DAU  - Pagani FDLA  - engPT  - Case ReportsPT  - Journal ArticleDEP - 20111024PL  - EnglandTA  - PerfusionJT  - PerfusionJID - 8700166SB  - IMCIN - Perfusion. 2012 Jan;27(1):71. - 22025358own - nlmstat- medlineda  - 20120116dcom- 20120529is  - 1477-111x (electronic)is  - 0267-6591 (linking)vi  - 27ip  - 1dp  - 2012 janti  - long-term use of the centrimag(r) ventricular assist system as a right      ventricular assist device: a case report.pg  - 65-70lid - 10.1177/0267659111424634 [doi]ab  - right ventricular failure (rvf) following implantation of a left ventricular      assist system (lvas) is associated with high morbidity and mortality.( 1-4 )      numerous centers have reported short-term use of the centrimag ((r)) ventricular       assist system (cvas) (levitronix llc, waltham, ma) for treatment of cardiogenic      shock, decompensated heart failure and right ventricular failure (rvf) following       lvas implantation.( 5-9 ) the present report reviews the clinical course of a      patient requiring long-term right ventricular support utilizing the cvas,      following a heartmate ((r)) ii lvas (thoratec corp. pleasanton, ca) implantation.      elevated cytotoxic antibody levels complicated the patient's treatment plan by      precluding orthotropic heart transplantation. the cvas operated for 304 days      without mechanical difficulty until replaced with the heartware ((r)) ventricular      assist system (heartware inc. miramar, fl).fau - griffith, k eau  - griffith kead  - cardiovascular center perfusion services, university of michigan hospitals, ann      arbor, mi, usa. kegriff@med.umich.edufau - jenkins, eau  - jenkins efau - stulak, jau  - stulak jfau - paugh, tau  - paugh tfau - pagani, f dau  - pagani fdla  - engpt  - case reportspt  - journal articledep - 20111024pl  - englandta  - perfusionjt  - perfusionjid - 8700166sb  - imcin - perfusion. 2012 jan;27(1):71. 